Sarcomas and mixed mesodermal tumors of the uterus;Mesenchymale Tumoren des Uterus

Therapeutische Umschau

Volumn 68, Issue 10, 2011, Pages 559-564

  Günthert, Andreas R ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GROWTH; CLINICAL FEATURE; HISTOPATHOLOGY; HUMAN; LEIOMYOSARCOMA; MIXED TUMOR; POSTMENOPAUSE; PROGNOSIS; TRANSVAGINAL ECHOGRAPHY; TUMOR CLASSIFICATION; UTERUS SARCOMA;

ADENOSARCOMA; CARCINOSARCOMA; ENDOMETRIAL STROMAL TUMORS; ENDOSONOGRAPHY; FEMALE; HUMANS; HYSTERECTOMY; LAPAROSCOPY; LEIOMYOMA; LEIOMYOSARCOMA; MIDDLE AGED; MIXED TUMOR, MESODERMAL; MIXED TUMOR, MULLERIAN; NEOPLASM STAGING; PERITONEAL NEOPLASMS; PROGNOSIS; ULTRASONOGRAPHY, DOPPLER, COLOR; UTERINE NEOPLASMS;

EID: 80053625939     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930/a000214     Document Type: Article

References (17)

1. D'Angelo E, Prat J. Uterine sarcomas: a review. Gynecol Oncol 2009; 116: 131-9.
2. Prat J. FIGO staging for uterine sarcomas. Int J Gynaecol Obstet 2009; 104: 177-8.
3. Harlow BL, Weiss NS, Lofton S. The epidemiology of sarcomas of the uterus. J Natl Cancer Inst 1986; 76: 399-402.
4. Ueda SM, Kapp DS, Cheung MK et al. Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths. Am J Obstet Gynecol 2008;198: 218 e1-6.
5. Köhler GH, Evert M. Handbuch und Bildatlas der uterinen Sarkome und Mischtumoren. De-Gruyter, Berlin, 2009.
6. Nordal RR, Thoresn SO. Uterine sarcomas in Norway 1956-1992: incidence survival and mortality. Eur J Cancer 1997; 33: 907-11.
7. Brooks SE, Zhan M, CVote T, Baquet CR. Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999. Gynecol Oncol 2004; 93: 204-8.
8. Parker WH, Fu YS, Berek JS. Uterine sarcoma in patients operated in for presumed leiomyoma and rapidly growing leiomyoma. Obstet Gynecol 1994; 83:414-8.
9. Valentin L. Imaging in gynecology. Best Pract Res Clin Obstet Gynaecol. 2006; 20: 881-906.
10. Aviram R, Ochshorn Y, Markovitch O et al. Uterine sarcomas versus leimoymas: gray-scale and Doppler sonographic findings. J Clin Ultrasound 2005; 33: 10-3.
11. Sahdev A, Sohaib SA, Jacobs I, Shephard JH, Oram DH, Reznek RH. MR imaging of uterine sarcomas. 2001; 177: 1307-11.
12. Umesaki N, Tanaka T, Miyama M et al. Positron emission tomography with (18)F-fluorodeoxyglucose of uterine sarcoma: a comparison with magnetic resonance imaging and power Doppler imaging. 2001; 80: 372-7.
13. Gonzalez Bosquet J, Terstriep SA, Cliby WA et al. The impact of multimodal therapy on survival for uterine carcinosarcomas. Gynecol Oncol 2010; 116: 419-23.
14. Amant F, Coosemans A, Debiec-Rychter, Timmerman D, Vergote I. Clinical management of uterine sarcomas. Lancet Oncol 2009; 10: 1188-98.
15. Jahns BG, Michael N, Brunnmayr G et al. Primary or secondary laparoscopy for staging in patients with uterine sarcoma. Eur J Obstet Gynecol Reprod Biol 2011; 154: 230-1.
16. Shah JP, Bryant CS, Kumar S, Ali-Fehmi R, Malone JM Jr, Morris RT. Lymphadenectomy and ovarian preservation in low-grade endometrial stromal sarcoma. Obstet Gynecol 2008; 112: 1102-8.
17. Garg G, Shah JP, Toy EP, Bryant CS, Kumar S, Morris RT. Stage IA vs. IB endometrial stromal sarcoma: does the new staging system predict survival? Gynecol Oncol 2010; 118: 8-13.